Pathway Background and Objectives
Human Immunodeficiency Virus (HIV) may be transmitted vertically from mother to newborn. Antiretroviral therapy (ARV) is effective in both preventing and treating HIV in perinatally exposed newborns. National guidelines from the National Institutes of Health and the Centers for Disease Control and Preventions were updated in 2026. In summary, infants are given perinatal HIV medications based on maternal risk factor stratification. Antiviral medication(s) for infants should be started within 6 hours of birth. Breastmilk feeding has important benefits for both the infants and mothers. Due to how effective antiviral medications are, guidelines allow women living with HIV to breastmilk feed their infants under certain criteria.
This clinical pathway is meant for use in the following settings: well-baby nursery, neonatal intensive care unit, pediatric inpatient unit, outpatient infectious diseases (ID) clinic, and primary care clinic. The specific objectives of the pathway are to:
• Standardize management to align with national recommendations to prevent or treat HIV in infants exposed to HIV-infected mothers
• Establish a standardized approach for counseling women living with HIV to support them in their decision about choice of infant feeding (mother's own milk, donor milk, or formula)
• Standardize care to align with national recommendations to prevent HIV transmission to infants with mothers living with HIV who choose to breastmilk feed their infants
• Facilitate pediatric ID outpatient care following the birth hospitalization